Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITEDInferred winner L1₹21.4 LQualified Make: ADCETRIS
Model: ADCETRIS
Title: INJ BRENTUXIMAB VEDOTIN 50MG 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002 | Make: ADCETRIS
Model: ADCETRIS
Title: INJ BRENTUXIMAB VEDOTIN 50MG | L1 | Qualified MII |
Tender Value
Refer Docs
EMD Value
₹1 L
Closing Date
27 Nov 2024, 9:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
INJ BRENTUXIMAB VEDOTIN 50MG
7040180
GEM/2024/B/5520717
Two Packet Bid
INJ BRENTUXIMAB VEDOTIN 50MG
30 days
Kerala; Kannur
Total value wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
₹3
50%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| INJ BRENTUXIMAB VEDOTIN 50MG | KANNUR | 12 | 30 days |
₹1 L
27 Nov 2024
6 Nov 2024
27 Nov 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7040180.pdf
GEM_BID
report_gem_garpts_16102024_9dyuke9skjfa_-1_2024-10-18-17-22-56_9585ee2463606787e8aa13c456168b01.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .